Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder

OBJECTIVE: A recent 3-month double-blind, placebo-controlled study demonstrated efficacy and safety of pediatric prolonged-release melatonin (PedPRM) for insomnia in children with autism spectrum disorder. This study examined the long-term effects of PedPRM treatment on sleep, growth, body mass inde...

Descripción completa

Detalles Bibliográficos
Autores principales: Malow, Beth A., Findling, Robert L., Schroder, Carmen M., Maras, Athanasios, Breddy, John, Nir, Tali, Zisapel, Nava, Gringras, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084705/
https://www.ncbi.nlm.nih.gov/pubmed/31982581
http://dx.doi.org/10.1016/j.jaac.2019.12.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084705/
https://www.ncbi.nlm.nih.gov/pubmed/31982581
http://dx.doi.org/10.1016/j.jaac.2019.12.007

Ejemplares similares